Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
39.48(c) 38.81(c) 39.42(c) 39.61(c) 39.05(c) Last
19 580 121 37 775 909 19 488 052 15 975 947 21 833 827 Volume
+0.46% -1.70% +1.57% +0.48% -1.41% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 72 838 M - -
Net income 2021 17 466 M - -
Net Debt 2021 26 268 M - -
P/E ratio 2021 13,3x
Yield 2021 4,03%
Sales 2022 60 525 M - -
Net income 2022 16 082 M - -
Net Debt 2022 21 015 M - -
P/E ratio 2022 13,8x
Yield 2022 4,24%
Capitalization 219 B 219 B -
EV / Sales 2021 3,36x
EV / Sales 2022 3,96x
Nbr of Employees 78 500
Free-Float 59,2%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Sector
Pharmaceuticals
Calendar
07/28Earnings Release
More about the company
Ratings of Pfizer, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about PFIZER, INC.
03:56pPFIZER  : Ohio ends incentive lottery with mixed vaccination results
AQ
03:28pLONDON VACCINE RACE : Mass events send new boroughs to the front
AQ
03:12pMODERNA  : NIH begins clinical trial testing COVID-19 vaccine in pregnant women
RE
12:02pMODERNA  : 'Likely link' between rare heart inflammation and Pfizer, Moderna vac..
RE
11:49aUS' CDC To Study Possible Link Between Heart Inflammation And Pfizer/BioNTech..
MT
10:24aFACTBOX : How GSK plans to fire-up its cash balance post split
RE
10:17aBIONTECH  : EMA - Two additional manufacturing sites for BioNTech Pfizer's COVID..
AQ
10:16aViiV Healthcare and Halozyme enter global collaboration and license agreement..
AQ
09:08aToday on Wall Street: We shall not be ruled by inflation fears
07:18aPFIZER  : Doses First Patient in Late-Stage Study of Combination Therapy for Pro..
MT
07:11aPfizer Says First Patient Dosed in Phase 3 Prostate-Cancer Trial
DJ
06:46aPFIZER  : First Participant Dosed in Pfizer's Pivotal Phase 3 TALAPRO-3 Combinat..
BU
02:11aDebate Intensifies Over A Vaccine IP Waiver's Impact On Future Pharma And Bio..
AQ
01:39aASTRAZENECA  : What you need to know about the coronavirus right now
RE
01:39aASTRAZENECA  : What you need to know about the coronavirus right now
RE
More news
News in other languages on PFIZER, INC.
05:11pCORONAVIRUS : un comité US se penche sur des problèmes cardiaques chez des jeune..
10:59aWDH/GSK treibt Umbaupläne voran - Direktes Börsenlisting für OTC-Sparte
10:56aPFIZER  : essai de phase III autour du cancer de la prostate
08:50aKORREKTUR : Aufspaltung soll Pharmakonzern GSK Wachstumssprung bescheren
06:25aCOVID  : 15,3 mln dosi Pfizer e Moderna a giugno, 14,5 mln a luglio
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 39,05 $
Average target price 42,34 $
Spread / Average Target 8,43%
EPS Revisions
Managers and Directors
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER, INC.6.09%221 725
JOHNSON & JOHNSON3.34%430 876
ROCHE HOLDING AG11.75%324 905
NOVARTIS AG2.56%209 282
ABBVIE INC.6.39%202 586
ELI LILLY AND COMPANY28.58%201 295